Æȷοì
Jeong Bae Park
Jeong Bae Park
JB lab & clinic
jblab.orgÀÇ À̸ÞÀÏ È®ÀÎµÊ - ȨÆäÀÌÁö
Á¦¸ñ
Àοë
Àοë
¿¬µµ
The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed ¡¦
C Vlachopoulos, P Xaplanteris, V Aboyans, M Brodmann, R Cífková, ...
Atherosclerosis 241 (2), 507-532, 2015
8482015
Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan
EL Schiffrin, JB Park, HD Intengan, RM Touyz
Circulation 101 (14), 1653-1659, 2000
8122000
Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR
X Chen, RM Touyz, JB Park, EL Schiffrin
Hypertension 38 (3), 606-611, 2001
5492001
Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension
JB Park, EL Schiffrin
Journal of hypertension 19 (5), 921-930, 2001
4572001
Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats
JB Park, RM Touyz, X Chen, EL Schiffrin
American journal of hypertension 15 (1), 78-84, 2002
2362002
Correlation of endothelial function in large and small arteries in human essential hypertension.
JB Park, F Charbonneau, EL Schiffrin
Journal of hypertension 19 (3), 415-420, 2001
2332001
Validation of non-invasive central blood pressure devices: ARTERY Society task force consensus statement on protocol standardization
JE Sharman, AP Avolio, J Baulmann, A Benetos, J Blacher, CL Blizzard, ...
European heart journal 38 (37), 2805-2812, 2017
2032017
Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function
EL Schiffrin, JB Park, Q Pu
Journal of hypertension 20 (1), 71-78, 2002
1832002
ETA Receptor Antagonist Prevents Blood Pressure Elevation and Vascular Remodeling in Aldosterone-Infused Rats
JB Park, EL Schiffrin
Hypertension 37 (6), 1444-1449, 2001
1732001
NAD (P) H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats
YM Park, MY Park, YL Suh, JB Park
Biochemical and biophysical research communications 313 (3), 812-817, 2004
1612004
Systolic hypertension: an increasing clinical challenge in Asia
JB Park, K Kario, JG Wang
Hypertension Research 38 (4), 227-236, 2015
1502015
Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1
JB Park, EL Schiffrin
American journal of hypertension 15 (2), 164-169, 2002
1482002
Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients
EL Schiffrin, Q Pu, JB Park
American journal of hypertension 15 (2), 105-110, 2002
1372002
Src is an important mediator of extracellular signal–regulated kinase 1/2–dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of ¡¦
RM Touyz, G He, XH Wu, JB Park, ME Mabrouk, EL Schiffrin
Hypertension 38 (1), 56-64, 2001
1202001
Role of c-Src in the regulation of vascular contraction and Ca2+ signaling by angiotensin II in human vascular smooth muscle cells
RM Touyz, XH Wu, G He, JB Park, X Chen, J Vacher, V Rajapurohitam, ...
Journal of hypertension 19 (3), 441-449, 2001
1192001
2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II—treatments of hypertension
J Shin, JB Park, K Kim, JH Kim, DH Yang, WB Pyun, YG Kim, GH Kim, ...
Clinical hypertension 21, 1-13, 2015
116*2015
Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension
H Choi, DH Cho, HH Shin, JB Park
Circulation journal 68 (4), 297-303, 2004
1042004
Association of angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia
H Choi, JY Kang, HS Yoon, SS Han, CS Whang, IG Moon, HH Shin, ...
Journal of Korean medical science 19 (2), 253, 2004
962004
Reduction of resistance artery stiffness by treatment with the AT1-receptor antagonist losartan in essential hypertension
JB Park, HD Intengan, EL Schiffrin
Journal of the renin-angiotensin-aldosterone system 1 (1), 40-45, 2000
942000
A prospective study of fatty liver index and incident hypertension: the KoGES-ARIRANG study
JH Huh, SV Ahn, SB Koh, E Choi, JY Kim, KC Sung, EJ Kim, JB Park
PLoS One 10 (11), e0143560, 2015
872015
ÇöÀç ½Ã½ºÅÛÀÌ ÀÛµ¿µÇÁö ¾Ê½À´Ï´Ù. ³ªÁß¿¡ ´Ù½Ã ½ÃµµÇØ ÁÖ¼¼¿ä.
ÇмúÀÚ·á 1–20